Replies to post #912 on SmurfVA's Random Picks

[SmurfVA]

Ned - Will look over the PDF..while we are on the subject Zack's..they just did a piece on FPMI..

Promising Phase II Data Reinforces Our Confidence in CardioPET
Data and images from FluoroPharma's (OTC BB:FPMI) ongoing phase II trial of its novel imaging agent, CardioPET, were presented yesterday (2/6/2014) at the Society of Nuclear Medicine and Molecular Imaging Meeting in Palm Springs, CA..

Summary: We cover FPMI with an Outperform rating and $2.15/share price target.

ref. http://scr.zacks.com/News/Press-Releases/Press-Release-Details/2014/FPMI020714/default.aspx

[SmurfVA]

DARA - ($0.57) $0.07 (14.00%) Did well today.